Hyper-activation of the inflammation-associated signaling pathways such as NF-κB, JAK/STAT, MAPK, and TGF-β is prevalent during the occurrence and progression of AIDs, including IBD, SA, and SLE. Here, TGFB1 is linked to inflammatory bowel disease.